Name: MarketsandMarkets Next-Gen Digital Pathology Conference
Start: 2023-03-23
End: 2023-03-24
Location: ILEC Conference Centre & Ibis London Earls Court, London

WHAT TO EXPECT

Innovative research in digital pathology
Understanding and integrating computational pathology & Cloud computing
Critical role of digital pathology and AI in clinical decision making
Examining the latest developments in imaging technologies
Application of digital pathology in drug discovery
Standardisation methods & guidelines- Quality assurance, control, and improvement
Machine learning and AI models for improved prediction performance
Overcoming challenges in image analysis
Use of digital pathology in artificial intelligence for prediction and for better patient identification for appropriate treatment

Participate in discussions with experts on how technology implementation can be improved
Recognize what digital pathology is and how it can be used in the practice of pathology
Attracting and retaining world-class pharma and biotech talent
Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods
Discuss the challenges associated with interfacing a digital pathology system
Discover the latest technology implementations in the industry
Discover best-in-class solutions during the workshop sessions
Interactive panel discussions

Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist, Presidents, Vice Presidents, Directors, Heads, Managers,
Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
Hospital Designations - Senior scientist, scientist, pathologist
Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Lab technicians
Hospitals - Department of Pathology Informatics and Digital Pathology. Department of Haematology, Department of Diagnostics Pathology, Department of Chemical pathology

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson Amal (M.) Asar, Consultant Histopathologist, NHS	08:55 - 09:00
Keynote Presentation – Digital Pathology and AI: A new future, An evolving Paradigm for Pathology and Precision Medicine Radha Krishnan, Executive Director and Clinical Pathology Lead, Merck	09:00 - 09:35
DIGITAL PATHOLOGY – STRATEGY, CHALLENGES AND SCOPE
Panel Discussion: Barriers for AI Adoption in Clinical Practice Emre Çağatay KÖSE, Computational Pathologist, The Institute of Cancer Research	09:35 - 10:10
Pathologists with their Heads in the Cloud; Moving Diagnoses Online Alistair Robson, Medical Director , Source LDPath	10:10 - 10:35
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:35 - 11:20
Veterinary Digital Pathology Research: Bridging the Knowledge Gap Jonathan Williams, Senior Lecturer, Veterinary Anatomic Pathology, Royal Veterinary College	11:20 - 11:50
Transforming your Lab for Digital Pathology Prasanth Perugupalli, Chief Product Officer, Pramana	11:50 - 12:20
Digital Pathology in Non-alcoholic steatohepatitis (NASH) Drug Discovery: Opportunity and Challenges? Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals	12:20 - 12:55
Lunch and Poster Presentation \| One-to-One Networking Meetings	12:55 - 14:00
Quantification of HBV positive hepatocytes in liver biopsies before and after nucleotide therapy Jens Brodbeck, Director, Pathobiology, Gilead Sciences	14:00 - 14:30
ROLE OF PHARMA IN DIGITAL PATHOLOGY
Digital pathology and AI adoption in Multi-modal clinical biomarker development Qing Li, Director of Clinical Pathology, Moderna	14:30 - 15:00
Evening Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:00 - 15:45
Role of digital Pathology in cancer diagnostics Amal (M.) Asar, Consultant Histopathologist, NHS	15:45 - 16:15
Dissection of histopathological analytic workflow and its spatial and clinical relevance in DCIS progression Priya Narayanan, Analytical Scientist in Digital Pathology and Tissue-based Artificial Intelligence, The Institute of Cancer Research	16:15 - 16:45
For You and Me: Advantages of a Large-Scale Clinical Workflow Together with a Pharma Research Data Repository Sunil Singhal, Chief of Digital Pathology Transformation, Baylor College of Medicine	16:45 - 17:15
Closing Remarks from the Chairperson Amal (M.) Asar, Consultant Histopathologist, NHS	17:15 - 17:15
Drinks Reception & Networking	17:15 - 17:15
End of Day 1	17:15 - 17:15

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals	08:55 - 09:00
Towards Safe & Robust AI for Image-guided Diagnosis and Intervention Mobarakol Islam, Senior Research Fellow in Medical Image Analysis, University College London	09:00 - 09:35
COMPUTATIONAL PATHOLOGY
Computational Pathology for Precision Medicine Emre Çağatay KÖSE, Computational Pathologist, The Institute of Cancer Research	09:35 - 10:15
Innovative research in digital pathology Heba Sailem, Senior Lecturer and Welcome Career Development Fellow, King's College London, UK	10:15 - 10:45
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:45 - 11:35
Identification of immune dysregulation triggered by SARS-CoV-2 infection in patients with diagnosed Long COVID Dr. Benjamin Krishna, Associate Principal Investigator, University of Cambridge	11:35 - 12:05
The use of Artificial Intelligence (AI) to optimise patient outcomes in sepsis. Peter Gayo Munthali, Trust Clinical Lead for antimicrobial stewardship, University Hospital of Coventry and Warwickshire NHS Trust	12:05 - 12:35
Artificial Intelligence-based histopathological grading of lung adenocarcinoma Xiaoxi Pan, Postdoctoral Training Fellow, ICR	12:35 - 13:00
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:00 - 14:00
AI FOR IMAGING AND DIGITAL IMAGE ANALYSIS
AI-based quantitation of bone marrow fibrosis to improve the assessment and classification of Myeloproliferative Neoplasm (MPN) patients. Hosuk Ryou, Postdoctoral Research Assistant, University of Oxford	14:00 - 14:35
Challenges and Advances of Deep Learning in Digital Pathology Nikolay Burlutskiy, Director, AI at AstraZeneca	14:35 - 15:05
Closing Remarks from the Chairperson Hu Sheng Qian, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals	15:05 - 15:05
Drinks Reception & Networking	15:05 - 15:05
End of the conference	15:05 - 15:05